查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600664

藥物委外研發機構服務市場：按類型、研究階段、治療領域、分子類型、最終用戶 - 2025-2030 年全球預測

Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥物委外研發機構服務市場規模預計為870億美元，預計2024年將達到963.1億美元，複合年成長率為10.97%，預計到2030年將達到1803.6億美元。

在製藥、生物技術和醫療設備業，CRO（合約研究委外研發機構）服務透過外包研究服務幫助加速產品開發、降低成本、更有效率地將新產品推向市場發揮重要作用。這些服務包括早期開發、臨床試驗管理、化驗服務、資料管理和監管諮詢。日益複雜的法規環境、不斷上升的藥物開發成本以及並非所有公司都持有內部專業知識的需求推動了對 CRO 服務的需求。 CRO 服務的應用程式跨越研發的各個階段，為尋求最佳化資源的公司提供靈活性和擴充性。最終用途產業包括製藥公司、生技公司、醫療設備製造商、學術研究機構和政府研究組織。

主要市場統計
基準年[2023] 870億美元
預測年份 [2024] 963.1億美元
預測年份 [2030] 1803.6億美元
複合年成長率（%） 10.97%

該市場受到多種成長要素的影響，包括生物技術的快速發展、對個人化醫療的重視以及製藥和生物技術公司研發支出的增加。隨著精準醫學的興起，將服務範圍擴展到基因組學和生物資訊學等新領域是一個潛在的商機。策略聯盟和收購增強了我們的服務能力和地理覆蓋範圍，提供了顯著的競爭優勢。挑戰包括維護資料安全和監管合規性，這需要大量投資和專業知識，以及成熟新興企業，這給定價策略和利潤率帶來壓力。也存在一些限制，例如潛在的業務效率低下以及對提供服務的行業經濟狀況的依賴。

投資的創新領域包括開發先進的資料分析解決方案、利用人工智慧和機器學習增強臨床試驗技術，以及專注於以患者為中心的方法來提高臨床試驗的註冊率和保留率。 CRO 市場的動態和競爭性質需要不斷適應技術進步和不斷變化的行業需求。能夠利用技術整合並保持敏捷營運模式的公司處於有利地位，可以抓住成長機會，同時降低相關的市場風險。

市場動態：快速發展的委外研發機構市場的關鍵市場洞察

藥品委外研發機構服務市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 加大醫藥研發投入
    • 生技藥品和核子醫學的擴展
    • 研究活動中更採用外包服務
  • 市場限制因素
    • 資料管理和完整性問題
  • 市場機會
    • CRO 採用數位化、敏捷製造和研發技術
    • 強調更先進的細胞和基因療法的新穎臨床試驗設計和通訊協定
  • 市場挑戰
    • 臨床研究中的病患招募與保留問題

波特五力：開拓委外研發機構服務市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對藥物委外研發機構服務市場的影響

外部宏觀環境因素在塑造合約藥物委外研發機構服務市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解藥品委外研發機構服務市場的競爭狀況

委外研發機構服務市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 藥物委外研發機構服務市場供應商績效評估

FPNV定位矩陣是評估委外研發機構服務市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃藥物委外研發機構服務市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對藥物委外研發機構服務市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 加大醫藥研發投入
      • 生技藥品和核子醫學的擴展
      • 研究活動中越來越多採用外包服務
    • 抑制因素
      • 資料管理和完整性問題
    • 機會
      • CRO引進數位化、敏捷製造/研發技術
      • 專注於更先進的細胞和基因療法的新臨床試驗設計和通訊協定
    • 任務
      • 臨床研究中的病患招募與保留問題
  • 市場區隔分析
    • 類型：實施臨床研究服務以管理臨床試驗的複雜性和持續時間
    • 實驗階段：需要具有強大真實資料和上市後支援能力的CRO
    • 治療領域：CRO服務在腫瘤藥物開發活動中的一貫優先地位
    • 最終用戶：需要學術和研究機構強大的基礎研究能力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥品委外研發機構服務市場：依類型

  • 臨床研究服務
  • 諮詢服務
  • 資料管理服務
  • 早期開發服務
    • 化學、製造、管理
    • 發現研究
    • 臨床前服務
      • 藥物動力學/動態
      • 毒性試驗
  • 化驗服務
    • 分析測試
      • 批次放行測試
      • 物理特性
      • 原料檢測
      • 穩定性測試
    • 生物分析測試

第7章 藥品委外研發機構服務市場試行階段

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第8章依治療領域分類的藥物委外研發機構服務市場

  • 心血管疾病
  • 皮膚科
  • 胃腸道
  • 泌尿系統和女性健康
  • 血液學
  • 免疫疾病
  • 感染疾病
  • 代謝疾病/內分泌學
  • 神經病學
  • 腫瘤學
  • 眼科
  • 精神病學
  • 呼吸系統疾病

第9章按分子類型分類的藥物委外研發機構服務市場

  • 細胞和基因治療疾病
  • 疫苗

第10章 藥品委外研發機構服務市場：依最終用戶分類

  • 學術機構
  • 醫療設備公司
  • 製藥和生物技術公司

第11章：美洲藥物委外研發機構服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章 亞太地區藥物委外研發機構服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲/中東/非洲藥品委外研發機構服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Lindas Health 推出“一體化皮膚科 CRO”，徹底改變了皮膚科臨床試驗
    • Alcent 與 BARDA 建立五年夥伴關係，推動醫療對策的分散臨床試驗
    • Paleos Healthcare GmbH 與 OCT Clinical GmbH 的策略合併擴大了歐洲的臨床研究
    • Vida Clinical Research 透過策略收購歐洲 CRO 加強全球影響力
    • EUROAPI 和 SpiroChem 之間的創新合作徹底改變了藥物開發中的 CRO-CDMO 整合
    • Maridose 成立創新型 CRO 團隊進行大麻藥物開發
    • Julius Clinical Research 獲得 Ampersand Capital Partners 的成長投資
    • Everest Clinical Research 宣布收購 August Research
    • PRC Clinical 與 TrialHub 合作提高臨床試驗效率和患者招募
    • OrganaBio 推出創新的細胞處理和冷凍保存服務以支持分散的臨床試驗
    • MedRhythms 選擇 Curavit 作為慢性中風分散臨床試驗的合約研究組織 (CRO)
    • 透過與世界各地的臨床試驗和所有治療方法的策略夥伴關係關係來創新醫療保健
    • ClinChoice 透過策略收購 CROMSOURCE 擴大全球影響力
    • Avanir 收購 Maxis：加強醫療技術開發和商業化
    • TFS Health Sciences 透過收購 Apple Tree CI Group 拓展視野
  • 戰略分析和建議
    • 維達臨床研究有限公司

公司名單

  • AccuLab Life Sciences
  • ACTIVA-CRO
  • Advanced Clinical Research Services, LLC
  • BioAgile Therapeutics Pvt. Ltd.
  • Caidya
  • Calian Group Ltd.
  • Celerion, Inc.
  • Charles River Laboratories International, Inc.
  • Clinical Trial Service BV by PCM Trials
  • Cromsource by ClinChoice
  • CTI Clinical Trial & Consulting
  • Distefar del Sur SL
  • Ergomed PLC
  • Firma Clinical Research, LLC
  • Frontage Holdings Corporation
  • Geistek Pharma SL
  • HCL Technologies Limited
  • Icon PLC
  • INQUIS
  • IQVIA Holdings Inc.
  • KCR SA
  • Laboratory Corporation of America Holdings
  • Leon Research, SL
  • Linical Co., Ltd.
  • Medpace Holdings, Inc.
  • Novotech Health Holdings
  • OPIS Srl
  • Oxon Epidemiology, SL
  • Parexel International Corporation
  • Pepgra
  • Pharmaron Beijing Co., Ltd.
  • Pivotal, SLU
  • PPD Inc. by Thermo Fisher Scientific Inc.
  • Prometrika, LLC
  • ProRelix Services LLP
  • PSI CRO AG
  • QualitecFarma SL
  • SGS SA
  • Syncro Clinical Research SRL
  • Syneos Health, Inc.
  • The Emmes Company, LLC
  • Veeda Clinical Research Limited
  • Vial Health Technology, Inc.
  • Worldwide Clinical Trials Holdings Inc.
  • WuXi AppTec Co., Ltd.
  • X7 Research
Product Code: MRR-5012464360F9

The Contract Research Organization Services Market was valued at USD 87.00 billion in 2023, expected to reach USD 96.31 billion in 2024, and is projected to grow at a CAGR of 10.97%, to USD 180.36 billion by 2030.

Contract Research Organization (CRO) services play a critical role in the pharmaceutical, biotechnology, and medical device industries by providing outsourced research services to accelerate product development, reduce costs, and improve the efficiency of getting new products to market. These services encompass early-phase development, clinical trial management, laboratory services, data management, and regulatory consulting, among others. The necessity for CRO services is driven by increasingly complex regulatory environments, the rising costs of drug development, and the need for specialized expertise that not all companies possess in-house. Their application spans various stages of research and development, offering flexibility and scalability to companies looking to optimize their resources. End-use industries include pharmaceuticals, biotechnology firms, and medical device manufacturers, along with academic and government research institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 87.00 billion
Estimated Year [2024] USD 96.31 billion
Forecast Year [2030] USD 180.36 billion
CAGR (%) 10.97%

The market is influenced by several growth factors, such as rapid advancements in biotechnology, a greater emphasis on personalized medicine, and increased R&D expenditure by pharmaceutical and biotechnology companies. Potential opportunities lie in expanding service offerings to include emerging fields like genomics and bioinformatics, which are gaining traction due to the rise of precision medicine. Strategic partnerships and acquisitions can enhance service capabilities and geographical reach, providing significant competitive advantages. Challenges include maintaining data security and regulatory compliance, which require significant investment and expertise, and the intense competition among established and emerging players, which pressures pricing strategies and margins. Limitations also include potential operational inefficiencies and dependence on the economic health of the industries they serve.

Innovation areas ripe for investment include developing advanced data analytics solutions, enhancing clinical trial technologies through AI and machine learning, and focusing on patient-centric approaches that improve enrollment and retention in trials. The nature of the CRO market is dynamic and competitive, necessitating continual adaptation to technological advancements and shifting industry demands. Companies that can leverage technological integration and maintain agile operational models are well-positioned to capture growth opportunities while mitigating associated market risks.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contract Research Organization Services Market

The Contract Research Organization Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing investments in pharmaceutical research and development
    • Growing penetration of biologics and nuclear medicines
    • Rise in adoption of outsourced services for research activities
  • Market Restraints
    • Concerns associated with data management and integrity
  • Market Opportunities
    • Adoption of digitized and agile manufacturing and research development techniques by CROs
    • Emphasis on novel clinical trial designs and protocols for more advanced cell and gene therapy
  • Market Challenges
    • Issues of patient recruitment and retention for clinical research

Porter's Five Forces: A Strategic Tool for Navigating the Contract Research Organization Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contract Research Organization Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contract Research Organization Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contract Research Organization Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contract Research Organization Services Market

A detailed market share analysis in the Contract Research Organization Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contract Research Organization Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contract Research Organization Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Contract Research Organization Services Market

A strategic analysis of the Contract Research Organization Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contract Research Organization Services Market, highlighting leading vendors and their innovative profiles. These include AccuLab Life Sciences, ACTIVA-CRO, Advanced Clinical Research Services, LLC, BioAgile Therapeutics Pvt. Ltd., Caidya, Calian Group Ltd., Celerion, Inc., Charles River Laboratories International, Inc., Clinical Trial Service B.V. by PCM Trials, Cromsource by ClinChoice, CTI Clinical Trial & Consulting, Distefar del Sur SL, Ergomed PLC, Firma Clinical Research, LLC, Frontage Holdings Corporation, Geistek Pharma S.L., HCL Technologies Limited, Icon PLC, INQUIS, IQVIA Holdings Inc., KCR S.A., Laboratory Corporation of America Holdings, Leon Research, S.L., Linical Co., Ltd., Medpace Holdings, Inc., Novotech Health Holdings, OPIS S.r.l., Oxon Epidemiology, S.L., Parexel International Corporation, Pepgra, Pharmaron Beijing Co., Ltd., Pivotal, S.L.U., PPD Inc. by Thermo Fisher Scientific Inc., Prometrika, LLC, ProRelix Services LLP, PSI CRO AG, QualitecFarma S.L., SGS S.A., Syncro Clinical Research SRL, Syneos Health, Inc., The Emmes Company, LLC, Veeda Clinical Research Limited, Vial Health Technology, Inc., Worldwide Clinical Trials Holdings Inc., WuXi AppTec Co., Ltd., and X7 Research.

Market Segmentation & Coverage

This research report categorizes the Contract Research Organization Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Clinical Research Services, Consulting Services, Data Management Services, Early Phase Development Services, and Laboratory Services. The Early Phase Development Services is further studied across Chemistry, Manufacturing & Control, Discovery Studies, and Preclinical Services. The Preclinical Services is further studied across Pharmacokinetics/Pharmacodynamics and Toxicology Testing. The Laboratory Services is further studied across Analytical Testing and Bioanalytical Testing. The Analytical Testing is further studied across Batch Release Testing, Physical Characterization, Raw Material Testing, and Stability Testing.
  • Based on Trial Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.
  • Based on Therapeutic Area, market is studied across Cardiovascular Disease, Dermatology, Gastrointestinal, Genitourinary & Women's Health, Hematology, Immunological Disorders, Infectious Diseases, Metabolic Disorders/Endocrinology, Neurology, Oncology, Ophthalmology, Psychiatry, and Respiratory Disorders.
  • Based on Molecule Type, market is studied across Cell & Gene Therapy Diseases and Vaccines.
  • Based on End-User, market is studied across Academic Institutes, Medical Device Companies, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing investments in pharmaceutical research and development
      • 5.1.1.2. Growing penetration of biologics and nuclear medicines
      • 5.1.1.3. Rise in adoption of outsourced services for research activities
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with data management and integrity
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of digitized and agile manufacturing and research development techniques by CROs
      • 5.1.3.2. Emphasis on novel clinical trial designs and protocols for more advanced cell and gene therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Issues of patient recruitment and retention for clinical research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Adoption of clinical research services to manage the complexity and duration of clinical trials
    • 5.2.2. Trial Phase: Need for CROs with strong capabilities in real-world data and post-market support
    • 5.2.3. Therapeutic Area: Consistent preference for CRO services in oncology drug development activities
    • 5.2.4. End-User: Need for strong foundational research capabilities by academic and research institutions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contract Research Organization Services Market, by Type

  • 6.1. Introduction
  • 6.2. Clinical Research Services
  • 6.3. Consulting Services
  • 6.4. Data Management Services
  • 6.5. Early Phase Development Services
    • 6.5.1. Chemistry, Manufacturing & Control
    • 6.5.2. Discovery Studies
    • 6.5.3. Preclinical Services
      • 6.5.3.1. Pharmacokinetics/Pharmacodynamics
      • 6.5.3.2. Toxicology Testing
  • 6.6. Laboratory Services
    • 6.6.1. Analytical Testing
      • 6.6.1.1. Batch Release Testing
      • 6.6.1.2. Physical Characterization
      • 6.6.1.3. Raw Material Testing
      • 6.6.1.4. Stability Testing
    • 6.6.2. Bioanalytical Testing

7. Contract Research Organization Services Market, by Trial Phase

  • 7.1. Introduction
  • 7.2. Phase I
  • 7.3. Phase II
  • 7.4. Phase III
  • 7.5. Phase IV

8. Contract Research Organization Services Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Disease
  • 8.3. Dermatology
  • 8.4. Gastrointestinal
  • 8.5. Genitourinary & Women's Health
  • 8.6. Hematology
  • 8.7. Immunological Disorders
  • 8.8. Infectious Diseases
  • 8.9. Metabolic Disorders/Endocrinology
  • 8.10. Neurology
  • 8.11. Oncology
  • 8.12. Ophthalmology
  • 8.13. Psychiatry
  • 8.14. Respiratory Disorders

9. Contract Research Organization Services Market, by Molecule Type

  • 9.1. Introduction
  • 9.2. Cell & Gene Therapy Diseases
  • 9.3. Vaccines

10. Contract Research Organization Services Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic Institutes
  • 10.3. Medical Device Companies
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Contract Research Organization Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Contract Research Organization Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Contract Research Organization Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Lindus Health revolutionizes dermatology trials with 'all-in-one dermatology CRO' launch
    • 14.3.2. Allucent secures 5-Year BARDA partnership to advance decentralized clinical trials for medical countermeasures
    • 14.3.3. Strategic merger between palleos healthcare GmbH and OCT Clinical GmbH expands clinical research in Europe
    • 14.3.4. Veeda Clinical Research Bolsters Global Presence with Strategic Acquisition of European CRO, Heads
    • 14.3.5. Innovative Partnership between EUROAPI and SpiroChem Revolutionizes CRO-CDMO Integration for Drug Development
    • 14.3.6. Maridose Launches Innovative CRO Group for Cannabis-Based Drug Development
    • 14.3.7. Julius Clinical Research Receives Growth Investment from Ampersand Capital Partners
    • 14.3.8. Everest Clinical Research Announces the Acquisition of August Research
    • 14.3.9. PRC Clinical and TrialHub Unite to Elevate Clinical Trial Efficiency and Patient Recruitment
    • 14.3.10. OrganaBio Launches Innovative Cell Processing and Cryopreservation Services to Support Decentralized Clinical Trials
    • 14.3.11. MedRhythms Choses Curavit as its Contract Research Organization (CRO) for a Chronic Stroke Decentralized Clinical Trial
    • 14.3.12. Innovating Healthcare through a Strategic Partnership between Worldwide Clinical Trials and Every Cure
    • 14.3.13. ClinChoice Expands Global Reach with Strategic Acquisition of CROMSOURCE
    • 14.3.14. Avania Acquires MAXIS: Enhancing Medtech Development and Commercialization
    • 14.3.15. TFS HealthScience Broadens Its Horizons with Appletree CI Group Acquisition
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Veeda Clinical Research Limited

Companies Mentioned

  • 1. AccuLab Life Sciences
  • 2. ACTIVA-CRO
  • 3. Advanced Clinical Research Services, LLC
  • 4. BioAgile Therapeutics Pvt. Ltd.
  • 5. Caidya
  • 6. Calian Group Ltd.
  • 7. Celerion, Inc.
  • 8. Charles River Laboratories International, Inc.
  • 9. Clinical Trial Service B.V. by PCM Trials
  • 10. Cromsource by ClinChoice
  • 11. CTI Clinical Trial & Consulting
  • 12. Distefar del Sur SL
  • 13. Ergomed PLC
  • 14. Firma Clinical Research, LLC
  • 15. Frontage Holdings Corporation
  • 16. Geistek Pharma S.L.
  • 17. HCL Technologies Limited
  • 18. Icon PLC
  • 19. INQUIS
  • 20. IQVIA Holdings Inc.
  • 21. KCR S.A.
  • 22. Laboratory Corporation of America Holdings
  • 23. Leon Research, S.L.
  • 24. Linical Co., Ltd.
  • 25. Medpace Holdings, Inc.
  • 26. Novotech Health Holdings
  • 27. OPIS S.r.l.
  • 28. Oxon Epidemiology, S.L.
  • 29. Parexel International Corporation
  • 30. Pepgra
  • 31. Pharmaron Beijing Co., Ltd.
  • 32. Pivotal, S.L.U.
  • 33. PPD Inc. by Thermo Fisher Scientific Inc.
  • 34. Prometrika, LLC
  • 35. ProRelix Services LLP
  • 36. PSI CRO AG
  • 37. QualitecFarma S.L.
  • 38. SGS S.A.
  • 39. Syncro Clinical Research SRL
  • 40. Syneos Health, Inc.
  • 41. The Emmes Company, LLC
  • 42. Veeda Clinical Research Limited
  • 43. Vial Health Technology, Inc.
  • 44. Worldwide Clinical Trials Holdings Inc.
  • 45. WuXi AppTec Co., Ltd.
  • 46. X7 Research

LIST OF FIGURES

  • FIGURE 1. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CHEMISTRY, MANUFACTURING & CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DISCOVERY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BATCH RELEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHYSICAL CHARACTERIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RAW MATERIAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CELL & GENE THERAPY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 215. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 222. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 224. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 225. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 226. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 241. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 242. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 243. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 244. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 245. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 250. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 251. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 252. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 253. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 254. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 258. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 259. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 260. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 261. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 262. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 263. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 267. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 268. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 270. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 271. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 272. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. GERMANY CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 276. GERMANY CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLI